Mini Review ARTICLE
Progesterone inhibition of oxytocin signaling in endometrium
- Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA
Expression of the oxytocin receptor (OXTR) in the endometrium of ruminant species is regulated by the ovarian steroids progesterone (P) and estradiol (E). Near the end of the estrous cycle, long-term exposure of endometrial epithelial cells to P results in loss of genomic P receptors (PGRs), leading to an increase in E receptors (ERs). Genomic regulation of the OXTR is mediated via suppression of ER signaling by P. Upon OT binding at the plasma membrane of endometrial cells, a signaling cascade is generated stimulating release of prostaglandin F2α (PGF2α). Transport of PGF2α to the ovary results in release of OT by luteal cells in a positive feedback loop leading to luteal regression. This signaling cascade can be rapidly blocked by exposing endometrial cells to physiologic levels of P. This mini review will focus on the mechanisms by which P may act to block OXTR signaling and the luteolytic cascade in the ruminant endometrium, with special focus on both non-genomic signaling pathways and non-receptor actions of P at the level of the plasma membrane. While this review focuses on ruminant species, non-classical blockage of OXTR signaling may be important for fertility in women.
In mammals, signaling by the neuropeptide oxytocin (OT) via receptors (OXTRs) in the uterus results in initiation of parturition [as reviewed by Kamel (2010)] and contributes to initiation of luteolytic events in some species (Lee et al., 2010). The effects of OT signaling via uterine OXTRs are especially well-characterized in ruminant species. The luteal steroid progesterone (P) can block OXTR signaling via several mechanisms, however, the exact mediator(s) of this response remain to be conclusively identified in uterine tissues.
Oxytocin and Oxytocin Receptor (OXTR)
OT is a neuropeptide with the amino acid sequence of Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2; OT is secreted primarily from the posterior pituitary, but also by the corpus luteum (CL) of several mammalian species such as swine, ruminants, and primates [as reviewed by Stormshak (2003)]. The OXTR is expressed in OT-target tissues (such as the uterus) and is a class 1 G-protein coupled receptor (GPCR) which primarily activates the G-protein αq/11 upon OT binding [as reviewed by Sanborn et al. (1995)]. Activation of the receptor by Gαq stimulates the enzyme phospholipase (PLC)β, which hydrolyzes phosphatidylinositol 4,5-bisphosphate, generating 1,2 diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Production of IP3 by the OT-stimulated uterine cell causes the endoplasmic reticulum to release stored calcium (Ca2+; Figure 1). Intracellular Ca2+ release activates protein kinase C (PKC), which phosphorylates many regulatory proteins (Blanks et al., 2007), while free arachidonic acid is cleaved from DAG and converted into prostaglandin F2α (PGF2α) in endometrial cells [as reviewed by Gimpl and Fahrenholz (2001)].
Figure 1. Progesterone (P) inhibition of oxytocin receptor (OXTR) signaling in endometrial cells. Binding of oxytocin (OT) to the OXTR activates the G-protein, Gαq/11. The activated G-protein phosphorylates the enzyme phospholipase Cβ (PLCβ), which cleaves phosphatidylinositol 4,5-bisphosphate into DAG and inositol 1,4,5-trisphosphate (IP3). Released IP3 induces intracellular calcium release (Ca2+) from the endoplasmic reticulum, and is then recycled into free inositol. Free arachadonic acid (AA) is cleaved from DAG by phospholipase A2 (PLA2) and then converted by cyclooxygenase 2 (COX2) into prostaglandin F2α (PGF2α). Blockage of this signaling cascade by P can occur by two mechanisms: (1) P binding to a membrane-associated binding protein that interacts with the OXTR, resulting in conformational changes to the receptor such that OT is not able to bind and/or the OXTR is unable to interact with the G-protein. (2) P overloading of the plasma membrane results in changes to membrane fluidity, preventing the OXTR from interacting with the G-protein. Both of these mechanisms of action would result in P-mediated decreased signaling of the OXTR.
Oxytocin-Mediated Luteolysis in Ruminant Species
Functional OXTRs are expressed in the endometrium of the uterus in ruminant species such as the ewe near the end of diestrus (Stevenson et al., 1994). At this time, OT secreted by large luteal cells of the CL (Fields and Fields, 1986) activates OXTR signaling in the endometrium resulting in secretion of PGF2α [as reviewed by Niswender et al. (2007)]. Endometrial PGF2α is transported directly via ovarian artery to the CL where it induces further release of OT (Lee et al., 2010), in a positive feedback loop that ultimately results in luteal regression. The ruminant conceptus secretes interferon tau (IFNT), which acts to block/prevent OXTR signaling and prolong luteal life span [as reviewed by Spencer et al. (2007)].
The involvement of OT and OXTR in luteal regression of primates is still controversial. Unlike ruminant CL, transplantation of the ovary away from the uterine blood supply does not prolong luteal lifespan in primates, indicating an intraluteal mechanism of luteolysis (Burford and Diddle, 1936; Beavis et al., 1969). Several studies in non-human primates suggest that OT increases P secretion from early luteal phase CL, and might be involved with maintenance of gap-junctions in luteal tissue (Khan-Dawood et al., 1998). More recently, expression of functional OXTR was reported in human luteinized granulosa cells (Saller et al., 2010). Activation of the OXTR by OT increases caspase signaling and induces morphological changes to luteinized granulosa cells associated with regression. Therefore, while there is evidence that the OXTR is involved in primate luteal regression, additional well-designed studies are needed to precisely define its role in primate luteolysis.
Effects of Progesterone on OXTR Gene Expression
Following ovulation and luteinization in the ewe, during diestrus there is an initial increase in expression of the genomic P receptor (PGR) in the uterine endometrial glands, and a concurrent absence of OXTRs. Blockage of endometrial OXTR expression by ligand-bound PGR is via an indirect mechanism resulting from P suppression of estrogen receptors (ERs) [as reviewed by Spencer and Bazer (2004)]. However, even when OXTR are expressed in endometrial cells, exposure of the endometrium to both estradiol (E) and P is absolutely necessary for OT to induce PGF2α secretion (Vallet et al., 1990). This is most likely due to P modulation and/or up-regulation of the necessary precursors in endometrial cells for prostaglandin production [as reviewed by Schams and Berisha (2002)]. The ruminant OXTR has been cloned; the promoter region contains several AP-1 and SP1 transcription factor recognition sites, as well as PGR half-sites (Fleming et al., 2006); genomic regulation of OXTR is mediated by ERα (ESR1) via these SP-1 sites, with no direct regulation by PGR. Similarly, IFNT also decreases ESR1 expression, thereby preventing ESR1-induced transcription of the OXTR gene (Fleming et al., 2006).
Increased expression of OXTR near parturition is noted in all mammalian species, including primates and ruminants; OXTR signaling is critical for initiation of myometrial contractions in ruminants (Wathes and Hamon, 1993). Genomic PGR is expressed in near-term myometrium, but PGR-coactivators decline prior to initiation of labor in women and mice (Condon et al., 2003). Administration of mifepristone (PGR antagonist) to women for blockage of PGR signaling can initiate labor [Cochrane review Hapangama and Neilson (2009)]. This suggests direct suppression of the OXTR near term by P via PGR signaling. But, regulation of OXTR gene function by P in pregnant myometrium is most likely indirect via immunosuppressive actions of P [as reviewed by Arck et al. (2007)]. Recently, binding sites for nuclear factor-kappa B p65 (RELA) and CCAAT/enhancer-binding protein (CEBP) were identified in the human OXTR gene promotor region (Khanjani et al., 2011). Expression of CEBP and RELA are increased in inflammatory responses (Adams et al., 2000), and mediators of both are increased in near-term myometrium of women (Khanjani et al., 2011).
Most notably, microarray analyses of P-response genes in murine endometrium at early pregnancy did not find that the Oxtr gene was altered by progestin replacement following ovariectomy (Jeong et al., 2005). Moreover, while mRNA for OXTR is expressed in rhesus luteal tissue during the mid-late luteal phase (identified by microarray analysis), it is not regulated by progestin [GEO dataset Series GSE12281 (Bishop et al., 2009)]. Given these data along with the previously noted studies in ruminants and women, it is likely that P regulation of the OXTR gene is indirect via modulation of other factors, such as ESR1 and immune factors.
Non-Genomic Inhibition of OXTR Signaling by P; Evidence of Biological Significance
Evidence for non-genomic inhibition of uterine OXTR signaling includes the observation that P and metabolites of P rapidly inhibit contractions of rat uteri within 2 min of treatment; this response is not opposed by treatment with the PGR antagonist RU 486 (Putnam et al., 1991). While these authors suggest that GABAA receptors mediate these effects, the rodent uterus also secretes OT, suggesting that the effects of P might be via non-genomic inhibition of rodent Oxtr signaling. Indeed, later studies from Grazzini et al. (1998) demonstrated that P induces a reduction in rat uterine OT signaling without a change in Oxtr mRNA expression.
Later studies in non-pregnant ruminants (Bogacki et al., 2002) demonstrated that P could inhibit OT-induced intracellular calcium release and PGF2α secretion by bovine endometrial tissue explants in the presence of actinomycin D, an inhibitor of DNA transcription/mRNA synthesis. However, subsequent experiments revealed P as well as pregnenolone, 17β-hydroxyprogesterone, the PR antagonist onapristone, and testosterone at micromolar (μM) concentrations were all able to interfere with OT-stimulated PGF2α secretion and intracellular calcium release (Duras et al., 2005). Inhibition of both OT-induced IP3 accumulation and PGF2α release from ovine endometrial explants was later observed at lower nM concentrations of P within hours (Bishop and Stormshak, 2006). This rapid, specific inhibition of OXTR signaling by P was confirmed in COS7 (African green monkey kidney) cells transfected with the ovine OXTR that lack PGRs (Bishop et al., 2008).
Incubation of myometrial strips from women at term pregnancy with P decreased OT-induced contractility within 20 min to an hour in a concentration–dependent manner, with maximal inhibition at 10 μM P (Chanrachakul et al., 2005). This could indicate a role for non-genomic inhibition of OXTR signaling by P to prevent premature onset of parturition.
Molecular Actions of Non-Genomic Inhibition of OXTR Signaling by P
Rapid inhibition of rodent Oxtr signaling is due to a P-mediated decrease in OT binding capacity, not binding affinity (Grazzini et al., 1998). Inhibition of OT binding is P dose-dependent and specific to the Oxtr (i.e., no effect on a related GPCR, vasopressin receptor). The observed inhibition by P of Oxtr function is at the level of the plasma membrane: P conjugated to bovine serum albumin, which prevents P from crossing through the plasma membrane easily, also inhibited membrane binding of OT. Specific and high-affinity binding sites for P were reported only in transfected CHO cells expressing the Oxtr. Moreover, high-affinity binding of P to Oxtr-expressing membranes was regulated by the state of the G-protein coupling to the receptor, based on additional experiments performed with the G-protein uncoupling reagent GTPγ S. These observations indicate that the interaction of P with the rodent Oxtr is possibly a direct steroid-receptor interaction, either by altering the conformation of the receptor or directly blocking the binding site for OT on the OXTR (Grazzini et al., 1998).
Later investigations of the ovine OXTR validated these initial studies in rodents. Isolated membrane fractions from the uterine luminal epithelium of artificially-cycled, ovariectomized ewes pre-incubated with P showed decreased OT binding, which was reversed by co-incubation with RU 486 (Dunlap and Stormshak, 2004). The presence of high-affinity membrane binding sites for P were identified, with P saturation occurring at 8 nM (Kd= 1.2 × 10−9 M). E, cortisol, testosterone, and arginine vasopressin failed to compete for the P binding site, however, P, R5020 (synthetic progestin), RU 486, and OT all bound to the same site on plasma membranes. A radioreceptor exchange assay demonstrated that pre-exposure of membranes to P significantly increased the number of P binding sites. Inhibition of OT binding to endometrial membranes by P was dose-dependent at a low (nM) steroid concentration (Bishop and Stormshak, 2006). However, unlike the rodent Oxtr (Grazzini et al., 1998) and native OXTR expression in ovine endometrial membranes (Dunlap and Stormshak, 2004), P does not decrease specific OT binding to the ovine OXTR when transfected into the COS7 (African green monkey kidney fibroblast) cell line (Bishop et al., 2008). Additionally, no specific P binding sites were identified in membranes of OXTR-transfected COS7 cells. This cell line (COS7) was chosen for transfection due to the fact that it lacked P receptors. While CHO (Chinese hamster ovary) cells are not reported to contain PGRs, the observed discrepancy between the two experiments (Grazzini et al., 1998; Bishop et al., 2008) could be due to the fact that CHO cells are of reproductive tract origin (unlike COS7) and may express a P binding protein.
Effects of progestins to inhibit a primate OXTR transfected into various cell lines was only investigated using μM concentration of steroid (Burger et al., 1999). This study reported that P inhibited the signaling of several related GPCRs (including acetylcholine receptor and vasopressin receptor) as well as the OXTR, suggesting that these effects are non-specific at μM concentrations of P.
Possible Non-Genomic Mediators of P-Inhibition of OXTR Signaling
As noted in several studies (Burger et al., 1999; Duras et al., 2005), μM concentrations of many classes of steroids have non-specific effects on OXTR signaling apparently in absence of specific binding of steroid to a single receptor. Non-receptor-mediated effects of various steroids, including P, were reported from studies of lipid domains using artificial membrane bilayers (Wenz and Barrantes, 2003). The lower the hydrophobicity of the steroid, (determined by the group bound to C17) the more disruptive the steroid is to lipid domains at μM molar concentrations. The composition and presence of these lipid domains in cell membranes may be critical to GPCR signaling (Bruno et al., 2012). P, promegestone, pregnenolone, 11 α-hydroxyprogesterone, and 17 α- hydroxypregnenolone all possess low hydrophobicity groups attached to C17 and demonstrate domain-disrupting activity at μM concentrations (Wenz and Barrantes, 2003). The previously mentioned study of Burger et al. (1999), found that the mechanism by which P inhibited signaling of several related GPCRs was possibly due to an observed decrease in plasma membrane fluidity. Therefore, the non-specific effect of several steroids on OXTR signaling at higher μM concentrations may be due to disruption of the lipid bilayer by steroid overloading of the plasma membrane. Steroid overloading of the membranes may affect OXTR coupling to the G-protein and activation of downstream signaling effectors by changing the fluidity of the plasma membrane (Gimpl et al., 2002), and preventing conformational changes of the receptor from inducing downstream effectors. This is a likely mechanism when local levels of steroids are high, such as during gestation (from placental P) and in the luteal tissue itself. In bovine CL, OXTRs are localized to pure preparations of small, steroidogenic luteal cells (SLCs), which release Ca2+ in response to OT-stimulus (Davis et al., 2010). If these SLCs are pre-incubated for 1 h with a high concentration of P (~100 μM), the OT-stimulated intracellular Ca2+ release is blocked. Because this phenomena was mimicked by replacing P with a cyclodextrin (methyl-β cyclodextrin), P might be acting to exclude cholesterol from the plasma membrane, thus altering membrane fluidity in these SLCs (Davis et al., 2010).
However, data generated from experiments in ovine endometrial tissue (Dunlap and Stormshak, 2004; Bishop and Stormshak, 2006), demonstrating a specific and saturable binding site for P that is closely associated with the OXTR suggests that rapid inhibition of OXTR signaling by P in reproductive tissues may be receptor mediated. A non-PGR, P receptor membrane component 1 (PGRMC1) and associated serpine mRNA binding protein 1 (SERBP1) are expressed in the uterus (endometrium and myometrium) of ruminants (Luciano et al., 2011) and non-human primates (Keator et al., 2012), and in human ovarian tissue (Luciano et al., 2011). Expression and actions of these proteins are extensively characterized in granulosa cells (Peluso et al., 2006), where the main function is preventing apoptosis. Given the fact that OXTR is expressed in primate luteal tissue and OT might contribute to intra-luteal initiation/progression of primate luteolysis (Saller et al., 2010); a membrane PR may prevent local OXTR signaling in the CL. Our research group observed expression of PGRMC1 protein present in the granulosa lutein cells of the rhesus macaque CL throughout the entire luteal phase, with intense staining noted in distinct subpopulations of cells clustered around the periphery of the CL (Bishop, Bogan, Slayden, Hennebold, and Stouffer, Unpublished). Expression of PGRMC1 mRNA in luteal tissue peaks at the late luteal phase, just prior the fall in P levels, and PGRMC1 protein is increased following chorionic gonadotropin exposure simulating early pregnancy (Bishop et al., 2011). In the ruminant uterus, evaluation of PGRMC1 expression by immunohistochemistry showed robust staining of bovine luminal epithelium (Luciano et al., 2011), the same cell type express OXTR (Leung et al., 2001). Possible effects and/or interactions between PGRMC1 and OXTR in the plasma membrane of both the endometrium and the CL remain to be investigated.
Other novel, non-genomic membrane PRs (mPRs) have been identified in the ovine uterus which may act to block local OXTR signaling (Ashley et al., 2009). While the function(s) of the mPR have yet to be described in the ewe, it reportedly stimulates intracellular calcium release. Three homologues of the mPR are present in the human uterus: mPRα, β, and γ (Fernandes et al., 2005). Endometrial mRNA expression of mPRα and mPRβ differ by the stage of the menstrual cycle; both decrease at the onset of parturition (Fernandes et al., 2005). These mPR are GPCRs, functioning to inhibit adenylcyclase activity (coupled to Gαi). The effect these mPRs might exert on OXTR signaling in uterine tissues remains to be investigated.
The genomic PGR also rapidly activates the MAPK pathway upon stimulation in breast cancer cells via a SRC kinase-like SH3 domain (Faivre et al., 2005; Skildum et al., 2005). The OXTR can also activate the MAPK pathway (Devost et al., 2008), but given the evidence that interference of OT binding to the OXTR occurs at the level of the plasma membrane (Grazzini et al., 1998; Dunlap and Stormshak, 2004; Bishop and Stormshak, 2006), involvement of the cytoplasmic/nuclear PGR to directly block OXTR signaling is unlikely. There is limited data on membrane-associated PGR, however, a microarray-based analysis did identify a membrane-associated mRNA encoding the PGR, suggesting localization to the plasma membrane (Diehn et al., 2006). Further studies are needed to clarify any non-genomic effects of PGR to block OXTR signaling.
There is evidence that P directly antagonizes OXTR signaling via a non-genomic mechanism, however, there are only a few studies, some with conflicting results (summarized in Table 1). Experiments conducted on the ruminant OXTR demonstrate rapid blockage of OT-stimulated secretion of PGF2α from endometrial tissue by P, which could lead to delayed luteolytic events. The best-characterized tissue to date of regulation of OXTR expression and OT signaling is the ruminant uterus, however, rapid inhibition of OT action by P remains to be investigated in the ruminant uterus during pregnancy. Inhibition of OXTR signaling may be due to non-receptor mediated events related to steroid overloading of plasma membranes, or via specific binding of P to one of several membrane-associated P receptors (Figure 1). Nevertheless, while there is ample evidence supporting an OXTR-associated P binding site in situ, further studies are needed to elucidate any involvement of membrane P receptors in blockage of OXTR signaling. The role of an ovarian OXTR in regulation of primate luteal tissue remains unclear, but P may act to block local OXTR signaling. Given recent studies identifying functional OXTR in primate luteal cells and P inhibition of OT-signaling in bovine SLCs (Davis et al., 2010), further experiments could help identify causes of fertility disorders associated with luteal function in women. Additionally, molecular mechanisms regulating parturition and onset of labor in women are still being defined. Greater understanding of OXTR signaling in the primate uterus might help reduce complications from onset of preterm labor (Hubinont and Debieve, 2011).
Conflict of Interest Statement
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
I would like to thank the editors Dr. Sandra L. Petersen and Dr. John J. Peluso for the invitation to submit this manuscript for the research topic “Non-Classical Progesterone Signaling Mechanisms.” Additional thanks to Dr. Fred Stormshak and Dr. Richard Stouffer for their kind review of this manuscript before submission.
Adams, D. S., Nathans, R., Pero, S. C., Sen, A., and Wakshull, E. (2000). Activation of a rel-A/CEBP-beta-related transcription factor heteromer by PGG-glucan in a murine monocytic cell line. J. Cell Biochem. 77, 221–233.
Arck, P., Hansen, P. J., Mulac Jericevic, B., Piccinni, M. P., and Szekeres-Bartho, J. (2007). Progesterone during pregnancy: endocrine-immune cross talk in mammalian species and the role of stress. Am. J. Reprod. Immunol. 58, 268–279. doi: 10.1111/j.1600-0897.2007.00512.x
Ashley, R. L., Arreguin-Arevalo, J. A., and Nett, T. M. (2009). Binding characteristics of the ovine membrane progesterone receptor alpha and expression of the receptor during the estrus cycle. Reprod. Biol. Endocrinol. 7, 42.
Bishop, C. V., Filtz, T., Zhang, Y., Slayden, O., and Stormshak, F. (2008). Progesterone suppresses an oxytocin-stimulated signal pathway in COS-7 cells transfected with the oxytocin receptor. Steroids 73, 1367–1374. doi: 10.1016/j.steroids.2008.06.014
Bishop, C. V., Hennebold, J. D., and Stouffer, R. L. (2009). The effects of luteinizing hormone ablation/replacement versus steroid ablation/replacement on gene expression in the primate corpus luteum. Mol. Hum. Reprod. 15, 181–193. doi: 10.1093/molehr/gap005
Bishop, C. V., Satterwhite, S., Xu, L., Hennebold, J. D., and Stouffer, R. L. (2011). Microarray analysis of the primate luteal transcriptome during chorionic gonadotrophin administration simulating early pregnancy. Mol. Hum. Reprod. 18, 216–227. doi: 10.1093/molehr/gar073
Bishop, C. V., and Stormshak, F. (2006). Nongenomic action of progesterone inhibits oxytocin-induced phosphoinositide hydrolysis and prostaglandin F2alpha secretion in the ovine endometrium. Endocrinology 147, 937–942. doi: 10.1210/en.2005-0869
Bogacki, M., Silvia, W. J., Rekawiecki, R., and Kotwica, J. (2002). Direct inhibitory effect of progesterone on oxytocin-induced secretion of prostaglandin F2a from bovine endometrial tissue. Biol. Reprod. 67, 184–188. doi: 10.1095/biolreprod67.1.184
Bruno, A., Costantino, G., De Fabritiis, G., Pastor, M., and Selent, J. (2012). Membrane-sensitive conformational states of helix 8 in the metabotropic Glu2 receptor, a class C GPCR. PLoS ONE 7:e42023. doi: 10.1371/journal.pone.0042023
Burger, K., Fahrenholz, F., and Gimpl, G. (1999). Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors. FEBS Lett. 464, 25–29. doi: 10.1016/S0014-5793(99)01668-3
Chanrachakul, B., Broughton Pipkin, F., Warren, A. Y., Arulkumaran, S., and Khan, R. N. (2005). Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium. Am. J. Obstet. Gynecol. 192, 458–463. doi: 10.1016/j.ajog.2004.07.077
Condon, J. C., Jeyasuria, P., Faust, J. M., Wilson, J. W., and Mendelson, C. R. (2003). A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc. Natl. Acad. Sci. U.S.A. 100, 9518–9523. doi: 10.1073/pnas.1633616100
Davis, T. L., Bott, R. C., Slough, T. L., Bruemmer, J. E., and Niswender, G. D. (2010). Progesterone inhibits oxytocin- and prostaglandin F2alpha-stimulated increases in intracellular calcium concentrations in small and large ovine luteal cells. Biol. Reprod. 82, 282–288. doi: 10.1095/biolreprod.109.079970
Duras, M., Mlynarczuk, J., and Kotwica, J. (2005). Non-genomic effect of steroids on oxytocin-stimulated intracellular mobilization of calcium and on prostaglandin F2alpha and E2 secretion from bovine endometrial cells. Prostaglandins Other Lipid. Mediat. 76, 105–116. doi: 10.1016/j.prostaglandins.2005.02.001
Faivre, E., Skildum, A., Pierson-Mullany, L., and Lange, C. A. (2005). Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators. Steroids 70, 418–426. doi: 10.1016/j.steroids.2005.02.012
Fernandes, M. S., Pierron, V., Michalovich, D., Astle, S., Thornton, S., Peltoketo, H., et al. (2005). Regulated expression of putative membrane progestin receptor homologues in human endometrium and gestational tissues. J. Endocrinol. 187, 89–101. doi: 10.1677/joe.1.06242
Fields, M. J., and Fields, P. A. (1986). Luteal neurophysin in the nonpregnant cow and ewe: immunocytochemical localization in membrane-bounded secretory granules of the large luteal cell. Endocrinology 118, 1723–1725. doi: 10.1210/endo-118-4-1723
Fleming, J. G., Spencer, T. E., Safe, S. H., and Bazer, F. W. (2006). Estrogen regulates transcription of the ovine oxytocin receptor gene through GC-rich SP1 promoter elements. Endocrinology 147, 899–911. doi: 10.1210/en.2005-1120
Gimpl, G., Wiegand, V., Burger, K., and Fahrenholz, F. (2002). Cholesterol and steroid hormones: modulators of oxytocin receptor function. Prog Brain Res 139, 43–55. doi: 10.1016/S0079-6123(02)39006-X
Jeong, J. W., Lee, K. Y., Kwak, I., White, L. D., Hilsenbeck, S. G., Lydon, J. P., et al. (2005). Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology 146, 3490–3505. doi: 10.1210/en.2005-0016
Keator, C. S., Mah, K., and Slayden, O. D. (2012). Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis. Mol. Hum. Reprod. 18, 308–319. doi: 10.1093/molehr/gas006
Khanjani, S., Terzidou, V., Lee, Y. S., Thornton, S., Johnson, M. R., and Bennett, P. R. (2011). Synergistic regulation of human oxytocin receptor promoter by CCAAT/enhancer-binding protein and RELA. Biol. Reprod. 85, 1083–1088. doi: 10.1095/biolreprod.111.092304
Lee, J., Mc Cracken, J. A., Banu, S. K., Rodriguez, R., Nithy, T. K., and Arosh, J. A. (2010). Transport of prostaglandin F(2alpha) pulses from the uterus to the ovary at the time of luteolysis in ruminants is regulated by prostaglandin transporter-mediated mechanisms. Endocrinology 151, 3326–3335. doi: 10.1210/en.2009-0948
Leung, S. T., Cheng, Z., Sheldrick, E. L., Derecka, K., Flint, A. P. F., and Wathes, D. C. (2001). The effects of lipopolysaccharide and interleukins-1alpha, -2 and -6 on oxytocin receptor expression and prostaglandin production in bovine endometrium. J. Endocrinol. 168, 497–508. doi: 10.1677/joe.0.1680497
Luciano, A. M., Corbani, D., Tessaro, I., Franciosi, F., Peluso, J. J., and Modina, S. (2011). Expression of progesterone membrane component-1 in bovine reproductive system druing estrus cycle. Eur. J. Histochem. 55:e27. doi: 10.4081/ejh.2011.e27
Niswender, G. D., Davis, T. L., Griffith, R. J., Bogan, R. L., Monser, K., Bott, R. C., et al. (2007). Judge, jury and executioner: the auto-regulation of luteal function. Soc. Reprod. Fertil. Suppl. 64, 191–206.
Peluso, J. J., Pappalardo, A., Losel, R., and Wehling, M. (2006). Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action. Endocrinology 147, 3133–3140. doi: 10.1210/en.2006-0114
Putnam, C., Brann, D., Kolbeck, R., and Mahesh, V. (1991). Inhibition of uterine contractility by progesterone and progesterone metabolites: mediation by progesterone and gamma-aminobutyric acidA receptor systems. Biol. Reprod. 45, 266–272. doi: 10.1095/biolreprod45.2.266
Saller, S., Kunz, L., Dissen, G. A., Stouffer, R., Ojeda, S. R., Berg, D., et al. (2010). Oxytocin receptors in the primate ovary: molecular identity and link to apoptosis in human granulosa cells. Hum. Reprod. 25, 969–976. doi: 10.1093/humrep/dep467
Sanborn, B. M., Qian, A., Ku, C. Y., Wen, Y., Anwer, K., Monga, M., et al. (1995). Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometrium. Adv. Exp. Med. Biol. 395, 469–479.
Skildum, A., Faivre, E., and Lange, C. A. (2005). Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases. Mol. Endocrinol. 19, 327–339. doi: 10.1210/me.2004-0306
Stevenson, K. R., Riley, P. R., Stewart, H. J., Flint, A. P. F., and Wathes, D. C. (1994). Localization of oxytocin receptor mRNA in the ovine uterus during the oestrous cycle and early pregnancy. J. Mol. Endocrinol. 12, 93–105. doi: 10.1677/jme.0.0120093
Vallet, J. L., Lamming, G. E., and Batten, M. (1990). Control of endometrial oxytocin receptor and uterine response to oxytocin by progesterone and oestradiol in the ewe. J. Reprod. Fertil. 90, 625–634. doi: 10.1530/jrf.0.0900625
Wathes, D. C., and Hamon, M. (1993). Localization of oestradiol, progesterone and oxytocin receptors in the uterus during the oestrous cycle and early pregnancy of the ewe. J. Endocrinol. 138, 479–492. doi: 10.1677/joe.0.1380479
Keywords: oxytocin, oxytocin receptor, progesterone, non-genomic steroid hormone action, non-classical steroid hormone action
Citation: Bishop CV (2013) Progesterone inhibition of oxytocin signaling in endometrium. Front. Neurosci. 7:138. doi: 10.3389/fnins.2013.00138
Received: 16 May 2013; Accepted: 18 July 2013;
Published online: 07 August 2013.
Edited by:John J. Peluso, University of Connecticut Health Center, USA
Reviewed by:James K. Pru, Washington State University, USA
Keith Inskeep, West Wirginia University, USA
Copyright © 2013 Bishop. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Cecily V. Bishop, Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Ave., Beaverton, OR 97006, USA e-mail: email@example.com